Cargando…
Need for Representation of Pediatric Patients with Obesity in Clinical Trials
Clinical trials are an integral aspect of drug development. Tremendous progress has been made in ensuring drug products are effective and safe for use in the intended pediatric population, but there remains a paucity of information to guide drug dosages in pediatric patients with obesity. This is co...
Autores principales: | Samuels, Sherbet, Vaidyanathan, Jayabharathi, Fletcher, Elimika Pfuma, Ramamoorthy, Anuradha, Madabushi, Rajanikanth, Burckart, Gilbert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605874/ https://www.ncbi.nlm.nih.gov/pubmed/37892303 http://dx.doi.org/10.3390/children10101640 |
Ejemplares similares
-
Pediatric dosing for locally acting drugs in submissions to the U.S. Food and Drug Administration between 2002 and 2020
por: Abulwerdi, Gelareh A., et al.
Publicado: (2023) -
Clinical pharmacology information in regulatory submissions and labeling: A comparative analysis of orphan and non‐orphan drugs approved by the FDA
por: Hsieh, Julie, et al.
Publicado: (2022) -
Pediatric Flatfoot: Is There a Need for Surgical Referral?
por: Vergillos Luna, Manuel, et al.
Publicado: (2023) -
Mood as Representation of Momentum
por: Eldar, Eran, et al.
Publicado: (2016) -
Why estimands are needed to define treatment effects in clinical trials
por: Keene, Oliver N., et al.
Publicado: (2023)